Owning or supervising a pharmacy requires meticulous detail to everything. When you are facing an investigation or are subject disciplinary action for alleged violations related to a DEA pharmacy inspection or a Board of Pharmacy inspection, you need attorneys who are just as diligent as you are.
We at Chapman Law Group assist pharmacy owners and supervising pharmacists (i.e., consulting pharmacists, pharmacists in charge and prescription department managers) across the U.S. who are under investigation. Our entire legal team is dedicated to defending licensed professionals like you, and we work regularly with DOH, LARA, BOP and DEA to resolve licensure matters.
The practice of pharmacy is highly regulated by a vast body of state and federal laws and regulations that are ever growing and changing. Pharmacy owners and managers are expected to stay compliant with these laws and regulations, and they are subject to routine compliance inspections. Failure to comply can result in discipline — including revocation of permits and/or DEA registrations — and even criminal charges.
That’s why it is important for pharmacy owners and managers to take proactive steps. Our seasoned team of compliance and health care defense attorneys will work with you to ensure compliance before your pharmacy is subject to a state or DEA pharmacy inspection.
The Board of Pharmacy can inspect a pharmacy for several reasons. These include inspections prior to permitting/licensing; inspections after receipt of an application for change of location or change of ownership; routine inspections to ensure compliance; and enforcement inspections.
Licensing/permitting inspections and routine Board of Pharmacy inspections focus on compliance with state statutes and regulations. The main areas of inspection include:
Our pharmacy law attorneys assist pharmacy owners and managers prior to Board of Pharmacy inspections to ensure compliance; during inspections to answer the inspector’s questions; and after inspections to address any deficiencies and defend administrative actions.
If the investigator finds deficiencies during the pharmacy inspection, they will issue an investigative report that outlines the alleged violations. The report is forwarded to the Department’s attorney for possible disciplinary action. Disciplinary action is usually initiated by an administrative complaint; however, the Department may issue an emergency suspension of a pharmacy’s license if they believe the conduct jeopardizes the health, safety or welfare of the public.
In Florida, the Department can conduct routine compliance and investigative inspections. Applicants for pharmacy permits consent to inspections prior to issuance of a permit. Obstruction during these pharmacy inspections are grounds for discipline.
In Michigan, the Board cannot conduct a pharmacy inspection without consent or an administrative search warrant. If the Board of Pharmacy asks for your consent to inspect, we advise that you contact our attorneys immediately to determine whether consent should be given. Only in emergency circumstances can the Board of Pharmacy inspect without consent or a warrant. Similar to Florida, applicants for pharmacy permits are subject to permitting inspections prior to issuance of a permit.
While most pharmacy inspections are routine compliance inspections, some aim to investigate things such as patient complaints, suspected diversion and fraud. Inspections led by complaints and suspected violations can quickly result in disciplinary action. Therefore, we strongly advise you to contact our attorneys immediately if you believe you are under investigation or subject to a pharmacy inspection.
Enforcement investigations can be difficult to distinguish from a routine inspection. Key things to look for are the presence of law enforcement, including DEA and OIG, together with state investigators (BOP/DOH); an administrative warrant authorizing the seizure of property; and investigators seeking to take statements from staff.
Our attorneys can help to:
Most importantly, if arrests are made, we can make sure your rights are protected and that you do not provide information that may be harmful later.
Similar to state inspections, the DEA conducts pharmacy inspections for various reasons, including investigation of a complaint and random inspections to ensure DEA compliance. Compliance-driven DEA pharmacy inspections generally target such matters as:
The DEA has the authority to bring criminal charges if they discover diversion or other serious violations during a “routine” inspection. Just as with state enforcement agencies, it’s crucial that you contact our attorneys immediately should the DEA arrive to inspect your pharmacy.
The DEA must have consent or an administrative search warrant to inspect a pharmacy. Our lawyers can help you determine whether to give consent; provide onsite representation to answer the investigator’s questions; be sure that pharmacy staff do not make incriminating statements to investigators; and monitor the situation so that the DEA does not exceed the scope of the search authorized by statute or a search warrant.
We understand the hard work it takes to manage a pharmacy, and we want to help pharmacy owners and pharmacy managers throughout the U.S. protect their pharmacy license and permits. Our attorneys are passionate about the defense of health professionals. We work aggressively to help their clients protect their license, career, assets and reputation.
If you believe your pharmacy is under investigation or is subject to a Board of Pharmacy inspection or DEA pharmacy inspection, contact one of our pharmacy law attorneys today.
We are dedicated to helping pharmacy practices, distributors and other registrants protect their DEA registration and defend against DEA enforcement action. Our goal is not only to protect the DEA registration of our clients, but to protect their other professional licenses, their career and their reputation from damage caused by DEA investigations and allegations of noncompliance.
We have 35 years of experience in DEA enforcement and inspections for pharmacy and healthcare clients throughout the U.S. Our offices are in:
Contact us today to learn more about what we can do for you.
Our national Healthcare Compliance lawyers negotiated with the DEA for over a year in order to avoid order to show cause and retain a pharmacist’s license.
Our attorneys argued to the OIG that exclusion for the prescribed time period was unreasonable under OIG regulations, and that most factors that would lead to a greater exclusion period were inapplicable.
We successfully demonstrated to the DEA that the pharmacist had the financial capacity to operate a pharmacy and also fully understood his corresponding responsibilities in regarding to narcotic medication dispensing and record keeping.
Chapman Law Group’s Ronald W. Chapman Sr. and Juan Santos hosted a CLE session on DOH, DEA, Medicaid at the Florida Pharmacy Association Law & Regulatory Conference in Sarasota.
Our national DEA attorneys are dedicated to defending prescribers and dispensers against DEA investigations, registration applications and denials, audits and raids. Here’s what healthcare providers should know about the DEA process, from our perspective.
The CDC Guidelines for prescribing controlled substances like opioids, and the DEA/DOJ investigations that follow, are putting physicians and their pain patients in a regulatory crunch.
This Medicare Advantage plan complaint filed against a physician to the state Board of Medicine is one for which doctors had best take heed.
There’s a simple, short answer for whether pharmacies can, carte blanche, defer a patient’s co-pays and deductibles. That answer is NO. Why Can’t Co-Pays and
Michigan OFFICE
1441 W Long Lake Road
Suite 310
Troy, MI 48098
T. 248.644.6326
F. 248.644.6324
CALIFORNIA OFFICE
5250 Lankershim Blvd.
Ste. 500
North Hollywood, CA 91601
T. 305.712.7177
FLORIDA OFFICES
6841 Energy Court
Suite 120
Sarasota, FL 34240
T. 941.893.3449
701 Waterford Way
Suite 340
Miami, FL 33126
T. 305.712.7177
Practice Areas
Attorneys
© CHAPMAN LAW GROUP. ALL RIGHTS RESERVED
